Highlights
NASDAQ: OMER       Omeros Corp
Last Price Today's Change   Day's Range   Trading Volume
15.42   -0.44 (2.77%)  14.685 - 16.61  488,293

Overview

 
Avg Volume (4 weeks):1,307,563
4 Weeks Range:12.00 - 27.00
4 Weeks Price Volatility (%):
22.80%
52 Weeks Range:8.36 - 27.00
52 Weeks Price Volatility (%):
37.88%
Average Price Target: 30.00
Price Target Upside/Downside: +14.58

Headlines



No recent Headlines for this stock.


Business Background

Omeros Corp is a United States based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

  Be the first to like this.
 


 

2389  5155  455  715 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 25.03+1.37 
 BAC 27.38-0.94 
 SPY 275.01-1.24 
 EEM 40.10+0.43 
 VXX 34.56+0.51 
 XLF 26.10-0.57 
 TOPS 1.97+0.70 
 QQQ 173.91+0.89 
 GE 12.38-0.18 
 HMNY 0.0170.00 
Partners & Brokers